Corrigendum to “Persistence of immunogenicity after seven COVID-19 vaccines given as third dose boosters following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK: Three month analyses of the COV-BOOST trial” [J Infect 84(6) (2022) 795–813, 5511]
Author(s)
Type
Journal Article
Date Issued
2023-05
Date Acceptance
2023-04-01
Citation
Journal of Infection, 2023, 86 (5), pp.540-541
ISSN
0163-4453
Publisher
Elsevier
Start Page
540
End Page
541
Journal / Book Title
Journal of Infection
Volume
86
Issue
5
Copyright Statement
© 2023 The Author(s). Published by Elsevier Ltd on behalf of The British Infection Association. This is an open access article under the CC BY license (http://
creativecommons.org/licenses/by/4.0/).
creativecommons.org/licenses/by/4.0/).
License URL
Identifier
https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000996350000001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=a2bf6146997ec60c407a63945d4e92bb
Subjects
Infectious Diseases
Life Sciences & Biomedicine
Science & Technology
Publication Status
Published
Date Publish Online
2023-04-12